Tongue Cancer Doctors Abroad — Page 2

Professor Yildirim is a leading authority in medical oncology at Anadolu Medical Center, specialising in targeted therapies and immunotherapy for complex head and neck cases.

• Treats tongue cancer using immunotherapy – biological treatments that help the immune system attack cancer cells
• Uses targeted therapy – drugs designed to block cancer growth by attacking specific molecules in tumours
• Co-authored the 'Handbook of Advanced Cancer Care Treatment' for specialist medical training
• Certified by the European Society of Medical Oncology (ESMO) for international practice standards

Dr. Rahib Hasanov is a medical oncologist. He graduated from Istanbul University Cerrahpaşa Faculty of Medicine (1999–2005). He completed an internal medicine residency (2009–2013) and a medical oncology fellowship at Marmara University (2015–2018). He also completed an observership at Houston Methodist Hospital (2006–2007).

He focuses on personalized oncology. His treatments include immunotherapy, targeted therapy, and novel agents. His clinical interests include gastrointestinal, breast, lung, and genitourinary cancers.

He attends national and international conferences. He welcomes patients from Turkey, Azerbaijan, Montenegro, Georgia, Uzbekistan, the Middle East, Europe, and the United States.

The doctor is an ECFMG and ESMO-certified medical and breast oncologist with over 20 years of experience, specializing in solid cancer, breast cancer, colorectal, and lung cancer treatment. Since 2016, the doctor has been a medical oncology specialist at Anadolu Medical Center.

The doctor graduated from Gülhane Military Medical Academy with a degree in general medicine and completed specialties in internal and medical oncology. The doctor has been a professor and associate professor at Gülhane Military Medical Academy, contributing significantly to medical education.

With over 110 papers on cancer management, the doctor is a member of several prestigious oncology organizations.

Professor Sezer Saglam is a senior medical oncologist at Istanbul Florence Nightingale Hospital with specialized expertise in managing complex gastrointestinal and head and neck cancers.

• Holds a professorship in medical oncology from Istanbul University Oncology Institute
• Specialises in gastrointestinal oncology and neuroendocrine tumour management
• Member of the European Society for Medical Oncology (ESMO)
• Active member of the American Society of Clinical Oncology (ASCO)
• Participates in the European Neuroendocrine Tumour Society (ENETS) clinical network

Dr. Mehmet Doğu Canoğlu is a radiation oncologist. He graduated from Kocaeli University Faculty of Medicine. He completed his residency in radiation oncology at Kocaeli University from 2006 to 2012.

He completed his compulsory service at Diyarbakır Training and Research Hospital. He then worked at Bağcılar Training and Research Hospital and at Medipol Mega University Hospital from 2015 to 2017. Since 2017, he has been a radiation oncologist at Anadolu Medical Center.

The doctor graduated from Ankara University Medical School and completed residency training in internal medicine at Ankara GATA Medical School. Specializing in medical oncology and hematology, the doctor completed a clinical fellowship in the USA. A pioneer in Turkey, the doctor was part of the team that performed the first bone marrow transplantation in the country. The doctor has served as a visiting lecturer at prestigious institutions in London and Switzerland. Holding the European Medical Oncology Certificate, the doctor is a founding member of both The Turkish Society of Medical Oncology and the Turkish Oncology Group. The clinical focus includes breast, gastrointestinal, lung cancers, lymphomas, and myeloma.

Professor Tahsin Ozadli is a medical oncology specialist who focuses on gastrointestinal and head and neck tumours at Valued Med Hub Hospitals.

• Trained at the Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
• Specialises in managing cancers of the oesophagus and upper digestive tract
• Uses chemotherapy and targeted biological therapies for advanced-stage cases
• Active clinical researcher with numerous published studies on oncology outcomes
• Expert in multidisciplinary care for complex head and neck malignancies

Professor Ozcan Yildiz is a leading medical oncologist at Medipol Mega University Hospital with a strong focus on complex tumour management and clinical research.

• Specialises in medical oncology for head and neck cancers, including malignant tongue tumours
• Contributing author to international research on neuroendocrine tumours and oncology outcomes
• Manages integrated treatment plans involving chemotherapy and immunotherapy for advanced cases
• Associate Professor at one of Turkey's largest university medical centres

Professor of oncosurgery and proctology

Associate Professor Tahsin Ozatli leads oncology care at Istinye University Liv Hospital, specialising in the management of complex gastrointestinal and head tumours.

• Promoted to Associate Professor in 2016 for his contributions to clinical oncology
• Previously served at the Ankara Oncology Clinic – one of Turkey's major cancer centres
• Specialises in managing gastrointestinal cancers that can affect the tongue and digestive tract
• Trained at the Erzurum Regional Training and Research Hospital in medical oncology protocols

Associate Professor Yusuf Acikgoz is a specialist medical oncologist who refined his expertise at Ohio State University, a world-leading centre for cancer research and clinical trials.

• Participated as a clinical investigator for CheckMate-649, a major Phase III immunotherapy trial
• Completed specialised training in immuno-oncology with the Central European Cooperative Oncology Group in Vienna
• Holds ECFMG certification and high scores in US medical licensing exams (USMLE)
• Maintains active membership with the American Society of Clinical Oncology

Associate Professor Nail Paksoy is a European-certified medical oncologist specialising in systemic treatments for solid tumours at Medipol Bahçelievler University Hospital.

• Holds ESMO Board Certification in Medical Oncology, an internationally recognised mark of specialist excellence
• Expert in Peptide Receptor Radionuclide Therapy (PRRT) for targeting metastatic neuroendocrine tumours
• Served as a sub-investigator in major international clinical trials for targeted immunotherapy
• Extensively published in medical journals on chemotherapy protocols and managing treatment toxicities